Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444 Meeting Abstract
| Authors: | Fong, L.; Fong, L.; Powderly, J.; Luke, J.; Hotson, D.; Sznol, M.; George, S.; Choueiri, T.; Rini, B.; Hellmann, M.; Kummar, S.; Hernandez-Aya, L.; Mahadevan, D.; Hughes, B.; Markman, B.; Riese, M.; Brody, J.; Renouf, D.; Heist, R.; Goodwin, R.; Weise, A.; Emens, L.; Willingham, S.; Kwei, L.; Laport, G.; Miller, R. |
| Abstract Title: | Refractory renal cell cancer (RCC) exhibits high adenosine A2A receptor (A2AR) expression and prolonged survival following treatment with the A2AR antagonist, CPI-444 |
| Meeting Title: | 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 6 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Nov 7-11 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2018-11-06 |
| Start Page: | 115 |
| Language: | English |
| PMCID: | PMC6220479 |
| PUBMED: | 30400822 |
| DOI: | 10.1186/s40425-018-0423-x |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: O45 |
